Literature DB >> 8111060

CD antigens 1993.

S F Schlossman1, L Boumsell, W Gilks, J M Harlan, T Kishimoto, C Morimoto, J Ritz, S Shaw, R L Silverstein, T A Springer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8111060

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.

Authors:  D Girard; R Paquin; A D Beaulieu
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins.

Authors:  N Rinaldi; M Schwarz-Eywill; D Weis; P Leppelmann-Jansen; M Lukoschek; U Keilholz; T F Barth
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

3.  Differential expression of beta 1, beta 3 and beta 4 integrins in sarcomas of the small, round, blue cell category.

Authors:  T Barth; P Möller; G Mechtersheimer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis.

Authors:  J E Freedman; J Loscalzo; S E Benoit; C R Valeri; M R Barnard; A D Michelson
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

Review 5.  Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development.

Authors:  Said Kdimati; Christina Susanne Mullins; Michael Linnebacher
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

6.  Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.

Authors:  Wei M Liu; Feng Zhang; Simon Moshiach; Bin Zhou; Chao Huang; Kamalakkannan Srinivasan; Seema Khurana; Yi Zheng; Jill M Lahti; Xin A Zhang
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.